Coronavirus: Dr Reddy’s launches Remdesivir for COVID-19 treatment in India
Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of COVID-19 patients hospitalized with severe symptoms.
<p>Dr Reddy's Laboratories Ltd on Wednesday (September 9) announced the launch of Remdesivir, meant for treatment of COVID-19 patients, under a brand name 'Redyx' in India.</p>
Dr Reddy's Laboratories Ltd on Wednesday (September 9) announced the launch of Remdesivir, meant for treatment of COVID-19 patients, under a brand name 'Redyx' in India.
<p>According to a press release from the drug maker, the launch is part of the licensing agreement with Gilead Sciences, Inc (Gilead) that grants Dr Reddys the right to register, manufacture and sell Remdesivir, a potential treatment for COVID-19, in 127 countries including India.<br /> </p>
According to a press release from the drug maker, the launch is part of the licensing agreement with Gilead Sciences, Inc (Gilead) that grants Dr Reddys the right to register, manufacture and sell Remdesivir, a potential treatment for COVID-19, in 127 countries including India.
<p>Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of COVID-19 patients hospitalized with severe symptoms.<br /> </p>
Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of COVID-19 patients hospitalized with severe symptoms.
<p>"Dr Reddy's Redyx is available in strength of 100 mg vial," it said.</p>
"Dr Reddy's Redyx is available in strength of 100 mg vial," it said.
<p>Chief executive officer of Branded Markets (India and Emerging Markets), Dr Reddy's Laboratories, MV Ramana said, "We will continue our efforts to develop products that address significant unmet needs of patients. The launch of Redyx reaffirms our commitment to bringing in critical medicine for patients suffering from COVID-19 in India."</p>
Chief executive officer of Branded Markets (India and Emerging Markets), Dr Reddy's Laboratories, MV Ramana said, "We will continue our efforts to develop products that address significant unmet needs of patients. The launch of Redyx reaffirms our commitment to bringing in critical medicine for patients suffering from COVID-19 in India."
Stay updated with the Breaking News Today and Latest News from across India and around the world. Get real-time updates, in-depth analysis, and comprehensive coverage of India News, World News, Indian Defence News, Kerala News, and Karnataka News. From politics to current affairs, follow every major story as it unfolds. Get real time updates from IMDon major cities' weather forecasts, including Rain alerts, Cyclonewarnings, and temperature trends. Download the Asianet News Official App from the Android Play Store and iPhone App Store for accurate and timely weather updates anytime, anywhere.